Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/4/23 17:15 | 10/2/23 | IMVT | Health | Drug | Pharmaceutical Preparations | Roivant Sciences Ltd. | X0 | DT | P | 58,000 | 38.00 | 0 | 1,526 | 2 | 79,805 | D | |||||||||||||||
10/7/22 16:32 | 10/6/22 | IMVT | Health | Drug | Pharmaceutical Preparations | Roivant Sciences Ltd. | X0 | T | P | 2,500 | 6.00 | 0 | 417 | 1 | 73,805 | D | |||||||||||||||
10/4/22 16:27 | 9/30/22 | IMVT | Health | BioPrd | Biological Products, (No Diag | Pande Atul | NY | D | P | 84 | 5.60 | 0 | 15 | 17 | 103 | I | |||||||||||||||
9/29/22 16:21 | 9/29/22 | IMVT | Health | BioPrd | Biological Products, (No Diag | Torti Frank | NY | D | P | 116 | 5.81 | 0 | 20 | 5 | 393 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |